Massive changes—including breakthroughs in digital health, the emergence of novel therapies, the rise of personalized care, and value-based care—are transforming health care. BCG helps health care organizations take action now so they can compete and thrive over the long term.
At the start of 2020, the global health care industry was already facing transformational changes driven by shifting consumer behaviors, the rise of disruptive competitors, changing regulations, and new alliances and mergers. To thrive in the face of such change—and in the postpandemic world—health care leaders need to reimagine their strategies, value propositions, and organizational capabilities. Our health care consulting teams help clients do so by adopting agile ways of working, accelerating innovation, advancing digital transformation, evolving go-to-market strategies, and driving growth and portfolio strategy through M&A. Across virtually every engagement, we help clients optimize capabilities through data, digital, and advanced analytics.
At BCG, we work across the health care value chain to help our clients navigate their most pressing challenges, including:
We do this through an unrelenting commitment to innovation, collaboration, and industry-leading expertise. At BCG, we aim to create positive change in the world—for our clients as well as for patients and society—by helping clients deliver medical breakthroughs, innovative cures, and transformative patient experiences.
Navigating Health Care Reform
Changes in policies affect the entire US health care system. BCG’s Center for US Health Care Reform and Evolution helps clients prepare and act.
Once a visionary ambition, synthetic control arms are poised to take off. Now is the time for pharma companies to identify opportunities and gain experience.
Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.
These BCG articles explain how payers, providers, health care systems, and services organizations can navigate uncertainty and thrive in the postpandemic world by reimagining their organizations.
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
Geoff Martha, chairman and CEO of Medtronic, highlights the innovative ways his teams addressed ventilator supply shortages, developed new products, and built strong partnerships to support the COVID medical response.
Lilly’s Dave Ricks is passionate about diversity and inclusion at a crucial time.
